CN114271485A - Composition with blood sugar regulating effect and preparation method thereof - Google Patents

Abstract

A composition with the function of regulating blood sugar and a preparation method thereof, wherein A powder is prepared from the following raw materials in parts by weight: soybean flour 350, milk powder 250, cocoa powder 200, wheat bran 33.5, calcium carbonate 30, Chinese yam 25, spirulina powder 20, almond 20, dark plum 20, konjaku flour 20, licorice 10, sodium alginate 10, vanillin 4.5, ferrous gluconate 1.04, zinc gluconate 0.8, aspartame 0.3, vitamin B₅0.1, 0.1 of vitamin E, and vitamin B₁0.01, vitamin B₂0.01, 0.01 of vitamin A, 0.002 of sodium selenite and 120.00002 of vitamin B; the powder B is prepared from the following raw materials in percentage by weight: 80% of bifidobacterium bifidum powder, 10% of lactobacillus acidophilus powder and 10% of streptococcus thermophilus powder. The raw materials are respectively weighed according to the formula amount, the powder preparation and the soybean powder are put into an oven for curing, sterilization, sieving and mixing, the powder A is bagged, the powder B is a capsule and the capsules are respectively packaged into a complete set of products, and the composition can supplement nutrition, reduce the food consumption and improve the effect of regulating blood sugar by food.

Description

Composition with blood sugar regulating effect and preparation method thereof

Technical Field

The invention relates to a composition with the function of regulating blood sugar, belonging to food with specific health care function.

Background

The etiology of diabetes is very complex, and many complications are serious, and the current main treatment method is to use medicines to control blood sugar. The hypoglycemic medicine is orally taken or injected with insulin. Insulin injections have side effects, and common side effects include hypoglycemia, anaphylaxis, lipodystrophy at the injection site, edema, ametropia, weight gain, etc. Where hypoglycemia is primarily associated with insulin dosage, which may occur if insulin is overdosed. There are many oral hypoglycemic drugs, some of which are not suitable for patients with contraindications, such as renal insufficiency, hepatic insufficiency, gastrointestinal reaction, etc. In addition, the method of taking the medicine also has contraindications and influences the efficacy of the medicine. Therefore, the medication needs to be controlled to be used and used according to the change of blood sugar. However, it is troublesome for the patient to accurately grasp the blood sugar changes. And food hypoglycemic method, such as selecting food, fruit, vegetable, tea, etc. The hypoglycemic effect is mainly because the hypoglycemic index is low and safe, but the hypoglycemic effect is slow. Yuan Siamese powder (original name Tian Sanqi tablet, sugar Qi Chong ji) is a product for regulating blood sugar by food, is a prior generation product of the applicant, reduces the drinking amount by supplementing nutrition and reduces the weight to control the blood sugar, is a health care food, has an auxiliary effect on controlling the increase of the blood sugar, and often causes people to have uncomfortable feelings such as dyspepsia and the like. The absorption is not smooth, so the effect is slow and not good. How to improve the effect of regulating blood sugar by food and improve the resistance to diabetes is a subject of continuous research and development of the inventors.

Disclosure of Invention

The purpose of the invention is: a composition having blood sugar regulating effect and its preparation method are provided, which can supplement nutrition, reduce food consumption, and improve blood sugar regulating effect of food.

The technical scheme of the invention is as follows: a composition with the effect of regulating blood sugar comprises powder A and powder B, wherein the powder A is prepared from the following raw materials in parts by weight:

(1) soybean flour 350, (2) milk powder 250, (3) cocoa powder 200, (4) wheat bran 38.12, (5) calcium carbonate 30, (6) Chinese yam 25, (7) spirulina powder 20, (8) almond 20, (9) dark plum 20, (10) konjaku flour 20, (11) licorice 10, (12) sodium alginate 10, (13) vanillin 4.5, (14) ferrous gluconate 1.04, (15) zinc gluconate 0.8, (16) aspartame powder 0.3, (17) vitamin B₅0.1, (18) vitamin E0.1, (19) vitamin B₁0.01, (20) vitamin B₂0.01, (21) vitamin A0.01, (22) sodium selenite 0.002, (23) vitamin B₁₂0.00002；

The powder B is prepared from the following raw materials in parts by weight:

bifidobacterium bifidum powder 28, lactobacillus acidophilus powder 3.5 and streptococcus thermophilus powder 3.5;

a method of making the composition:

1) preparation of powder A

Weighing Chinese yam, almond, dark plum, liquorice and wheat bran according to a formula proportion, respectively crushing, sieving and sterilizing for later use;

secondly, placing the soybean flour with the formula amount in an oven for curing at the temperature of 100-110 ℃ to remove beany flavor for later use;

thirdly, the konjak powder, the aspartame powder, the milk powder, the ferrous gluconate, the cocoa powder, the zinc gluconate, the calcium carbonate, the spirulina powder and the sodium alginate in the formula amount are respectively sieved for later use.

Mixing the materials to prepare a mixed material;

fifthly, the vitamin B is weighed according to the formula amount₁Vitamin B₂Vitamin B₅Vitamin B₁₂Adding vitamin A, vitamin E, sodium selenite and vanillin into the mixture, mixing uniformly, and subpackaging into powder A bags 30g each;

2) preparation of powder B

Weighing Bifidobacterium bifidum powder, Lactobacillus acidophilus powder and Streptococcus thermophilus powder in proportion, mixing, and subpackaging into powder B capsules, each capsule being filled with 0.35 g;

3) and packaging the powder bag A and the powder capsule B in a complete set.

The eating method and the eating amount are as follows:

a powder bag: the food is taken 1.5 hours before the middle meal and the evening meal, and the food is taken 30g in two bags each day.

And B, powder capsule: 6 granules are taken every day, each granule is filled with 0.35g, and the granules are eaten together with the powder A.

The trade name of the powder A is as follows: siamese powder, Tiansanqi tablet, glucose tablet; the trade name of the powder B is as follows: tiansanqi changle capsule.

The diet structure and the food intake of patients with diabetes are controlled first. The invention A powder (Tiansanqi Siamese powder, original Tiansanqi Xiaotangqi granule) is mainly prepared from soybean powder, milk powder, cocoa powder, konjak powder, wheat bran, spirulina powder and the like as main raw materials, Chinese medicinal components such as Chinese yam, dark plum, almond, liquorice and the like are added, and the powder is orally taken before meals, and is used for pertinently supplementing high protein, trace elements, zinc, selenium, iron, calcium and vitamins according to the nutritional status of a diabetic patient after controlling the dietary structure and the intake amount of the diabetic patient and various nutrients lacked in the body; the Chinese yam, the dark plum, the almond, the liquorice and the like regulate the functions of the spleen and the stomach, so that symptoms such as malnutrition and the like can not appear even if the food consumption is reduced, and the aim of regulating the blood sugar is fulfilled. The B powder (Tiansanqichangle capsule) is a micro-ecological preparation, consists of bifidobacterium bifidum, lactobacillus acidophilus and streptococcus thermophilus, and has the health-care functions of improving the gastrointestinal tract function and regulating the intestinal flora. The powder B enters the intestinal tract of a human body, firstly, components in the powder A are converted into small molecules from macromolecules through the powder B (probiotics), so that the absorption by the human body is easy, and the blood sugar reducing effect of the powder A (Siamese powder) is improved; secondly, the cocoa powder, the konjaku flour, the yam, the dark plum and other substances are rich in active polysaccharide, oligosaccharide, organic acid and other substances, and the probiotics carry out digestion, decomposition and conversion processes on the substances, and meanwhile, the probiotics are beneficial to the self proliferation and restore the micro-ecological balance of the organism. Thirdly, the probiotics control the growth and reproduction of harmful bacteria, improve the autoimmune capability and increase the target efficacy by improving the biological balance of intestinal flora. Fourthly, the taken probiotics participate in the energy metabolism of the human body, decompose some toxic and harmful substances in the human body and provide a plurality of vitamins, essential amino acids and polypeptides for the human body. The researchers found through animal experiments that the probiotics can effectively reduce blood sugar, plasma total cholesterol, low-density lipoprotein and the like, thereby assisting Siamese powder to improve a plurality of inducing factors of type II diabetes. The powder A and the powder B are matched, and the functions are as follows: the soybean powder, the cocoa powder and the like in the powder A have an expansion effect in the digestion process of a human body, so that the stomach has obvious satiety, the ingestion of other foods can be reduced, and the powder A is orally taken before meals, so that the food consumption is effectively controlled, and the hunger feeling is avoided; meanwhile, the powder B is orally taken, and after probiotics in the powder B are activated in the stomach for a period of time, the satiety effect generated by food and the powder A after eating is converted into nutrition which is easy to be absorbed by human bodies, so that the powder A and the powder B are taken together before eating, the purposes of reducing the food consumption, reducing the weight to control the blood sugar, supplementing the nutrition, avoiding the phenomena of dyspepsia and the like are realized. The combination of the powder A and the powder B improves the effects of A, B in regulating blood sugar, reducing blood fat and reducing weight of obese people, thereby improving the aims of insulin deficiency and insulin resistance. The results of mouse tests show that the product of the invention has no toxic side effect on the viscera of the mouse, and has certain improvement effect on the symptoms of obesity, polydipsia, drinking water, hyperglycemia, hyperlipidemia and the like of the diabetic mouse.

Traditional Chinese medicine holds that the essence of all diseases of human beings is yin-yang imbalance, and the same is true of diabetes. In clinical practice, it is appreciated that type II diabetes is mainly of deficiency syndrome, and even with excess syndrome, it is also of deficiency origin and excess origin. "Yin Ping Yang Mi and Shen Zhi Qiang", which is the final result of health and recovery from diseases, is emphasized by Huangdi's classic. The balance is achieved by coordinating yin and yang and coordinating mutually. The probiotics in the formula B has the functions of assisting human body nutrition metabolism, immunoregulation and the like, is used together with the Siamese powder A to maintain the human body nutrition balance, thereby improving the effects of regulating the dietary structure, reducing the weight and regulating the blood sugar, and fully playing the role of 'enabling the yang to be in the shade'. The regulation results of the traditional Chinese medicine between groups based on syndrome differentiation and typing are not different, and the regulation method is verified to have a positive two-way regulation effect on the yin-yang imbalance state of type II diabetes.

Detailed Description

Example 1

A composition with blood sugar regulating effect comprises powder A and powder B, wherein the powder A is prepared from the following raw materials: (23 raw materials in total, 1000g)

The powder B is prepared from the following raw materials:

bifidobacterium bifidum powder 28g Lactobacillus acidophilus powder 3.5 g; the total content of Streptococcus thermophilus powder 3.5g is 35g

The powder A is also named as: siamese powder (original name Tian Sanqi tablet comprising glucose control granules); the powder B is named as Tiansanqi Changle capsule.

A method of making the composition:

1) preparation of powder A

Weighing Chinese yam, almond, dark plum and liquorice and wheat bran according to a production formula, respectively crushing, sieving and sterilizing for later use;

secondly, placing the soybean flour with the formula amount in an oven for curing at the temperature of 100-110 ℃ to remove beany flavor for later use;

and thirdly, sieving the konjak powder, the aspartame, the milk powder, the ferrous gluconate, the cocoa powder, the zinc gluconate, the calcium carbonate, the spirulina powder and the sodium alginate according to the formula ratio respectively for later use.

Mixing the materials to prepare a mixed material;

fifthly, the vitamin B is weighed according to the formula amount₁Vitamin B₂Vitamin B₅Vitamin B₁₂Vitamin A, vitamin E, sodium selenite and vanillaAdding the extract into the mixed materials, uniformly mixing, and subpackaging into powder A bags, wherein each bag contains 30g of the extract;

2) preparation of powder B

Weighing Bifidobacterium bifidum powder, Lactobacillus acidophilus powder and Streptococcus thermophilus powder in proportion, mixing, and subpackaging into powder B capsules each of which is 0.35 g;

3) and packaging the powder A bag and the powder B capsule respectively. The product is sold and used in a set.

The eating method and the eating amount are as follows:

a powder bag: the food is taken 1.5 hours before the middle meal and the evening meal, and the food is taken 30g in two bags each day.

And B, powder capsule: 6 granules are taken every day, each granule is filled with 0.35g, and the granules are eaten together with the powder A.

The experimental report is as follows:

the conclusion of a research on the treatment effect of a Tiansanqi product on a type II diabetes model mouse is published in an important laboratory of the department of enzyme engineering education of the university of Life sciences college of Jilin, 4 Ri Jilin, 8 months and 2021: the experimental result shows that the Tiansanqi product can reduce the weight growth speed of db/db mice to a certain extent, reduce the fasting blood glucose value of the mice, relieve the increase of diet and drinking water of the mice caused by diabetes, improve the diabetes symptoms of the mice and has no toxic or side effect on visceral organs of the mice. The results of the mouse glucose tolerance experiment show that the Tian Sanqi administration has no obvious effect of reducing the peak value of blood sugar, and the Tian Sanqi high-dose group can reduce the blood sugar value (P <0.05) of the mouse after intragastric glucose administration and accelerate the serum glucose metabolism of the mouse. The level of glycated hemoglobin in the blood can reflect the glycemic control of the patient over 8-12 weeks. The glycosylated hemoglobin level of the model group db/db mouse is extremely high, after 8 weeks of administration of Tian Sanqi products, the glycosylated hemoglobin level in the blood of the mouse is extremely remarkably reduced (P <0.001), and the model group db/db mouse generates insulin resistance, beta cells secrete and release more insulin, so that hyperinsulinemia is caused, glucose metabolism disorder is presented, and vicious circle with insufficient beta cell function is caused. Improve insulin resistance and achieve the good effect of reducing blood sugar. After 8 weeks of administration of the high-dose group, the serum insulin level of the mice was reduced by 40.1% (P <0.001), after 8 weeks of administration of the medium-dose group, by 31.2% (P <0.001), and after 8 weeks of administration of the low-dose group, by 24.1% (P <0.001), as compared with the model group. Pyruvate kinase is one of the major rate-limiting enzymes in glycolysis, catalyzes phosphoenolpyruvate to generate ATP, and plays an important role in glucose metabolism. Compared with normal mice, the serum pyruvate kinase level of db/db mice is obviously reduced, and the glycolysis process of the body is seriously inhibited. After 8 weeks of administration, the serum pyruvate kinase levels increased by 70.2% (P <0.001) in the mice of the three-odd high dose group. Glycogen synthase kinase-3 (GSK-3) is a multifunctional serine/threonine kinase ubiquitous in eukaryotes and plays an important role in sugar metabolism. Meanwhile, GSK-3 remarkably increases the insulin resistance of the body and is a generally accepted target for treating diabetes at present. In this study, serum glycogen synthase kinase-3 levels were significantly elevated in db/db mice. After 8 weeks of administration, serum glycogen synthase kinase-3 levels were reduced by 34.0% (P <0.001) in the thirty-third high dose group mice compared to the model group. The experimental results show that the abnormal increase of the levels of hepatic glycogen and muscle glycogen of the model group db/db mice is probably caused by excessive eating and glucose metabolism disorder. After 8 weeks of administration, the liver glycogen and myoglycogen of the mice in the treatment group are obviously reduced on average (P <0.01), and the liver glycogen and myoglycogen levels are close to those of normal mice. Hyperglycemia, hypertension and hyperlipidemia become common pathological phenomena in clinical diabetes at present. Diabetic patients often have symptoms of lipid metabolism disorder, and hyperlipidemia is one of the important factors in the development of diabetic nephropathy [15 ]. In the study, compared with a blank group of mice, the serum total cholesterol level, triglyceride level and density lipoprotein cholesterol level of a db/db mouse model group are obviously increased (P is less than 0.001), and the lipid metabolism of a mouse body is disordered. After 8 weeks of administration, the total cholesterol level, triglyceride level and density lipoprotein cholesterol level in blood serum of each treatment group are remarkably reduced (P is less than 0.001), wherein the total cholesterol level of the Tian Sanqi medium dosage group is reduced by 37.5%, the triglyceride level is reduced by 37.2%, and the high density lipoprotein cholesterol is reduced by 35.7%. As a congenital diabetes model, the development process of db/db mouse is similar to that of human type II diabetes, and the diabetic nephritis complications are easy to occur due to a large number of microvascular complications [16 ]. In the experiment, a db/db mouse model is adopted to investigate the treatment effect of the Tiansanqi product on the type II diabetes, and the result shows that the Tiansanqi product has certain improvement effect on obesity, multiple drinking and drinking, hyperglycemia and hyperlipidemia of the diabetes mouse.

The beneficial effects of the present invention are illustrated by clinical observations below.

Clinical data

The subject group of the invention is under the coordination of Jilin medical college, Jilin province Chinese medicine academy, Changchun city Chinese medicine institute, Jilin province people hospital, Changchun Chinese medicine university, 3 months to 2015-4 months in 2015, 52 cases of II type diabetes mellitus are randomly adjusted in clinic according to the diagnosis sequence, wherein 34 cases of men, 18 cases of women, 45-75 years old, 51 years old on average, 6 months to 8 years old and 3 years old, 25 cases of qi-yin deficiency type (weakness and fatigue, frequent micturition, drinking urine, red face, soreness and weakness of waist and knees, dry throat and dry mouth, cold limbs, pale tongue with white fur and deep and thready weak pulse) are differentiated according to the diagnosis of traditional Chinese medicine; qi deficiency type 10 cases (debilitation, spontaneous perspiration, pale complexion, numbness of limbs, frequent micturition, loose stool, white fur, and weak pulse); yin deficiency type 10 cases (feverish sensation in the palms, soles and chest, dry mouth, polydipsia, night sweat, hunger, frequent micturition, turbid urine, red tongue with little coating, deep, thready and rapid pulse); yang deficiency type 7 cases (aversion to cold, cold limbs, weakness of feet and knees, lassitude, pale tongue with white coating, slow pulse and weak pulse). Blood glucose before meal (normal value 4.0-6.1mmol/L, 6 cases > 15mmol/L, 14 cases > 10mmol/L, 17 cases > 8mmol/L, 15 cases > 6.1 mmol/L; glycated hemoglobin (normal < 6.1mg/dl) > 9mg/dl in 5 cases, > 8mg/dl in 10 cases, > 7mg/dl in 19 cases, > 6.1mg/dl in 18 cases, with an average of 7.5 + -1.05 mg/dl; 34 cases of patients with blood sugar control by oral administration, 12 cases of patients with insulin injection and 6 cases of patients with oral administration and injection.

Method of regulation

Regulating the initial stage, continuously using oral western medicines or insulin injection in the whole medical record group, and taking Jiaole capsule 2 times a day, 3 granules each time 30 minutes to 1.5 hours before meal; taking 30g of glucose tablet 1.5 hours before meal 2 times a day. The blood sugar before meal is monitored every 10 days, the dosage of western medicine for oral administration and insulin for injection is adjusted, and the dosage of Changle capsule and glucose snack is not changed. 3 months is a treatment course, and after two treatment courses, glycosylated hemoglobin is detected and a case is made.

Regulating result

After 1 month of regulation, 11 cases of blood sugar details in the whole group are reduced (the mean value of blood sugar is reduced after more than 3 times of monitoring is reduced) by more than 1.5 mmol/L), the reduction of oral western medicines and insulin injection is started, and after 2 months, 18 cases of blood sugar details are reduced; after one treatment course, the blood sugar level of 25 cases is reduced, the blood sugar of 11 cases reaches the normal value, 8 cases stop taking the western medicines orally, and 2 cases stop injecting insulin. After two treatment courses, the blood sugar level of 44 cases is reduced (84.6%); normal for 25 sugars, (48%); 15 cases stop using western medicines, or insulin; 35 cases (67.3%) of glycated hemoglobin had decreased index, 8 cases (15.4%) of glycated hemoglobin had reached normal value, and the mean glycated hemoglobin was 6.9. + -. 1.03mg/dl, and the comparative difference between before and after adjustment was statistically significant (P < 0.05). After two courses of treatment are adjusted, the clinical symptoms of each group are improved according to syndrome differentiation of the traditional Chinese medicine. Index reduction of blood glucose and glycated hemoglobin: 21 cases of qi-yin deficiency, 8 cases of qi-deficiency, 9 cases of yin-deficiency, and 6 cases of yang-deficiency. The regulation results between the types have no statistical significance (P > 0.05). The Tiansanqi product is proved by human body tests to be safe to eat and free from toxic and side effects.

Claims (2)

1. The composition with the effect of regulating blood sugar is characterized by consisting of powder A and powder B, wherein the powder A is prepared from the following raw materials in parts by weight:

(1) soybean flour 350, (2) milk powder 250, (3) cocoa powder 200, (4) wheat bran 38.12, (5) calcium carbonate 30, (6) Chinese yam 25, (7) spirulina powder 20, (8) almond 20, (9) dark plum 20, (10) konjaku flour 20, (11) licorice 10, (12) sodium alginate 10, (13) vanillin 4.5, (14) ferrous gluconate 1.04, (15) zinc gluconate 0.8, (16) aspartame powder 0.3, (17) vitamin B₅0.1, (18) vitamin E0.1, (19) vitamin B₁0.01, (20) vitamin B₂0.01, (21) vitamin A0.01, (22) sodium selenite 0.002, (23) vitamin B₁₂ 0.00002；

The powder B is prepared from the following raw materials in parts by weight:

bifidobacterium bifidum powder 28, lactobacillus acidophilus powder 3.5 and streptococcus thermophilus powder 3.5;

the trade name of the powder A is as follows: siamese powder, Tiansanqi tablet, glucose tablet; the trade name of the powder B is as follows: tiansanqi changle capsule.

2. A process for preparing the composition of claim 1: the method is characterized in that:

1) preparation of powder A

Weighing Chinese yam, almond, dark plum, liquorice and wheat bran according to a formula proportion, respectively crushing, sieving and sterilizing for later use;

secondly, placing the soybean flour with the formula amount in an oven for curing at the temperature of 100-110 ℃ to remove beany flavor for later use;

thirdly, the konjak powder, the aspartame powder, the milk powder, the ferrous gluconate, the cocoa powder, the zinc gluconate, the calcium carbonate, the spirulina powder and the sodium alginate in the formula amount are respectively sieved for later use.

Mixing the materials to prepare a mixed material;

fifthly, the vitamin B is weighed according to the formula amount₁Vitamin B₂Vitamin B₅Vitamin B₁₂Adding vitamin A, vitamin E, sodium selenite and vanillin into the mixture, mixing uniformly, and subpackaging into powder A bags 30g each;

2) preparation of powder B

Weighing Bifidobacterium bifidum powder, Lactobacillus acidophilus powder and Streptococcus thermophilus powder in proportion, mixing, and subpackaging into powder B capsules, each capsule being filled with 0.35 g;

3) and packaging the powder bag A and the powder capsule B in a complete set.